Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study - Scorecard - MDSpire

Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study

  • By

  • Vivien Greese

  • Tamina Schenck

  • Maria Adams

  • Eva Jenz

  • Marti Juanola-Falgarona

  • Annika Wülfing

  • Christine Hagemann

  • Tobias Tenenbaum

  • February 15, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Acute Respiratory Infections on Pediatric Emergency Room Visits for Children Under 5: Findings from the Initial Season (2023/24) of the RISE Study

At a Glance

CategoryDetail
ConditionAcute respiratory infections (ARI) in children under 5 years
Key MechanismsViral pathogens including RSV, Rhinovirus, and Influenza cause URTI and LRTI; seasonal peaks in winter
Target PopulationChildren younger than 60 months presenting with ARI symptoms in an emergency room
Care SettingPediatric emergency room of a tertiary medical center in Berlin

Key Highlights

  • RSV infections contribute significantly to morbidity and mortality in children under 5 years.
  • Multiplex-PCR testing in the ER setting enables pathogen-specific diagnosis of URTI and LRTI.
  • Physician antibiotic prescription decisions are influenced by respiratory panel test results and clinical course.

Guideline-Based Recommendations

Diagnosis

  • Use nasopharyngeal multiplex real-time PCR panels for rapid identification of respiratory pathogens in children with ARI.
  • Perform additional laboratory diagnostics such as CRP and white blood cell count to support clinical assessment.

Management

  • Base antibiotic prescription decisions on respiratory pathogen test results and clinical symptoms to avoid unnecessary antibiotic use.
  • Monitor illness duration and symptom severity to guide treatment and hospitalization decisions.

Monitoring & Follow-up

  • Follow up with caregivers 30 days post-ER visit to assess clinical course and outcomes.
  • Use standardized questionnaires and quality of life assessments for comprehensive patient monitoring.

Risks

  • High morbidity and mortality associated with RSV infections in young children.
  • Potential overuse of antibiotics if viral etiology is not confirmed.

Patient & Prescribing Data

Children under 5 years presenting with ARI symptoms in the ER

Physician antibiotic prescribing is adjusted based on multiplex-PCR respiratory panel results and clinical progression, aiming to reduce unnecessary antibiotic use.

Clinical Best Practices

  • Enroll children with acute URTI or LRTI symptoms ≤7 days duration for accurate surveillance.
  • Separate data collection personnel from treating physicians to avoid bias in clinical management.
  • Offer multilingual study materials to accommodate diverse patient populations.
  • Use multiplex-PCR testing routinely in ER to identify viral pathogens and guide management.
  • Collect follow-up data to evaluate long-term outcomes and quality of life.

References

Original Source(s)

Related Content